134 Grants (Page 1 of 6)
2008
A PHASE II PHARMACOKINETIC STUDY OF THE TRANSDERMAL CONTRACEPTIVE SYSTEM AND
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-36-7641), $4,543USD, 12/01/2007 -- 05/31/2008
 
PATIENT EVALUATION FOR POTENTIAL AIDS CLINICAL TRIAL PARTICIPANTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-36-7577), $69,967USD, 12/01/2007 -- 05/31/2008
2007
A PHASE II PHARMACOKINETIC STUDY OF THE TRANSDERMAL CONTRACEPTIVE SYSTEM AND
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-35-8334), $19,057USD, 12/01/2006 -- 11/30/2007
 
PATIENT EVALUATION FOR POTENTIAL AIDS CLINICAL TRIAL PARTICIPANTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-35-8270), $293,476USD, 12/01/2006 -- 11/30/2007
2006
A PHASE II PHARMACOKINETIC STUDY OF THE TRANSDERMAL CONTRACEPTIVE SYSTEM AND
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-34-5235), $1,463USD, 12/01/2005 -- 11/30/2006
 
PATIENT EVALUATION FOR POTENTIAL AIDS CLINICAL TRIAL PARTICIPANTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-34-5145), $216,369USD, 12/01/2005 -- 11/30/2006
 
PREVALENCE OF HPV DNA IN HIV INFECTED WOMEN WHO HAVE INITIATED HAART (A5029)
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-34-5164), $2,193USD, 12/01/2005 -- 11/30/2006
2005
DEPO-MEDROXYPROGESTERONE ACETATE AND SELECTED PROTEASE INHIBITOR
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-33-0800), $5,560USD, 07/12/2005 -- 11/30/2005
 
EVALUATION OF METABOLIC COMPLICATIONS ASSOCIATED WITH ANTIRETROVIRAL MEDICATIONS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-33-0786), $5,560USD, 07/12/2005 -- 11/30/2005
 
HIV-INFECTED SUBJECTS WHO PARTICIPATED IN ACTG 388 &HAVE <200 HIV-1 RNA A5116
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-33-0775), $19,065USD, 07/12/2005 -- 11/30/2005
 
PATIENT EVALUATION FOR POTENTIAL AIDS CLINICAL TRIAL PARTICIPANTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-33-0289), $216,868USD, 07/12/2005 -- 11/30/2005
 
PREVALENCE OF HPV DNA IN HIV INFECTED WOMEN WHO HAVE INITIATED HAART (A5029)
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-33-0765), $1,590USD, 07/12/2005 -- 11/30/2005
2004
DEPO-MEDROXYPROGESTERONE ACETATE AND SELECTED PROTEASE INHIBITOR...
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-32-0800), $19,433USD, 12/01/2003 -- 11/30/2004
 
EVALUATION OF METABOLIC COMPLICATIONS ASSOCIATED WITH ANTIRETROVIRAL MEDICATIONS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-32-0786), $2,332USD, 12/01/2003 -- 11/30/2004
 
HIV-Infected Subjects Who Participated in ACTG 388 &Have <200 HIV-1 RNA A5116
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-32-0775), $22,544USD, 12/01/2003 -- 11/30/2004
 
Patient Evaluation for Potential AIDS Clinical Trial Participants
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-32-7619), $227,761USD, 12/01/2003 -- 11/30/2004
 
Prevalence of HPV DNA in HIV infected women who have initiated HAART (A5029)
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-32-0765), $1,555USD, 12/01/2003 -- 11/30/2004
 
Prolongation of Viro.success, options for Viro.failure in HIV infected (ACTG372)
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-32-7629), $8,552USD, 12/01/2003 -- 11/30/2004
2002
COMPARISON OF THE VIROLOGIC EFFICACY OF NULFINAVIR/DMP 266 IN COMBINATION
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-30-0628), 12/01/2001 -- 11/30/2002
 
ORAL ISOTRETINOIN VS OBSERVATION FOR LOW GRADE CERVICAL DYSPLASIA IN
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-30-0645), 12/01/2001 -- 11/30/2002
 
PATIENT EVALUATION FOR POTENTIAL AIDS CLINICAL TRIAL PARTICIPANTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-30-0289), 12/01/2001 -- 11/30/2002
 
PHASE II STUDY OF THE PROLONGATION OF VIROLOGIC SUCCESS AND OPTIONS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-30-0636), 12/01/2001 -- 11/30/2002
 
RANDOMIZED DOUBLE BLIND STUDY OF THE ANTIVIRAL ACTIVITY OF DIDANOSINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-30-0620), 12/01/2001 -- 11/30/2002
 
VIROLOGIC AND IMMUNOLOGIC ACTIVITY OF CONTINUED LAMIVUDINE VERSUS DELAVIRDINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-30-0630), 12/01/2001 -- 11/30/2002
2001
COMPARISON OF THE VIROLOGIC EFFICACY OF NULFINAVIR/DMP 266 IN COMBINATION
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-29-0628), 12/01/2000 -- 11/30/2001